Kineticos Ventures Invests in biotechs looking to disrupt how drugs are developed, diseases are diagnosed and patients are treated. We focus on the areas of greatest medical need: Oncology, Neurosciences, and Rare Diseases. We believe that disruptive technologies such as Cell and Gene Therapy, Gene Editing, mRNA/RNAi will dramatically change